Holen Sie sich die Stockscreener-App
148.64
0.07%
-0.1782
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$148.46
Offen:
$148.96
24-Stunden-Volumen:
590.51K
Relative Volume:
0.06
Marktkapitalisierung:
$366.87B
Einnahmen:
$65.51B
Nettoeinkommen (Verlust:
$8.93B
KGV:
41.83
EPS:
3.5532
Netto-Cashflow:
$14.12B
1W Leistung:
-2.16%
1M Leistung:
+15.38%
6M Leistung:
+26.68%
1J Leistung:
+75.35%
1-Tages-Spanne:
$147.89
$149.23
1-Wochen-Bereich:
$146.28
$152.80
52-Wochen-Spanne:
$77.58
$156.92
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
148.70 | 366.28B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,133.49 | 1.00T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
268.44 | 648.55B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
248.75 | 439.62B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
138.57 | 261.73B | 54.66B | 13.58B | 16.05B | 7.0171 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co. stock gains as Guggenheim raises price target on oncology optimism - AD HOC NEWS
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
Merck & Co. stock heads into the open after a 1.0 percent drop - AD HOC NEWS
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock outperforms competitors despite losses on the day - marketwatch.com
1 No-Brainer ETF I'm Loading Up on in 2026 and Beyond - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - TradingView
Merck Animal Health Supports Next Generation of Bovine Veterinarians with $90,000 in Scholarships - American Ag Network
Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating - marketscreener.com
Merck's CEO and research chief will speak online Sept. 14 - Stock Titan
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
The Hashgraph Group, Merck, and PwC Germany Develop Solution for Cocoa Traceability and Digital Product Passports - marketscreener.com
Merck & Co. stock gains on Wells Fargo price target hike and cancer vaccine momentum - AD HOC NEWS
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap - DirectorsTalk Interviews
California State Teachers Retirement System Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Amundi Has $1.59 Billion Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Saudi Central Bank - MarketBeat
NBH Bank Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Old Mission Investment Co LLC Makes New $1.34 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Oakmont Investment Advisors Inc. Invests $3.10 Million in Merck & Co., Inc. $MRK - MarketBeat
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Maloon Powers Pitre Higgins & Dennehy LLC Invests $882,000 in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - marketwatch.com
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
NEOS Investment Management LLC Purchases 40,020 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by TD Waterhouse Canada Inc. - MarketBeat
Concurrent Investment Advisors LLC Has $36.09 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Burford Brothers Inc. Sells 7,962 Shares of Merck & Co., Inc. $MRK - MarketBeat
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - reuters.com
Nykredit A S Takes $100.08 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Decreased by Secure Asset Management LLC - MarketBeat
Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference - BioSpace
Nwam LLC Acquires 10,124 Shares of Merck & Co., Inc. $MRK - MarketBeat
Northwestern Mutual Wealth Management Co. Sells 40,376 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE: MRK) digital chief holds stock units vesting through 2029 - Stock Titan
Proficio Capital Partners LLC Purchases 17,526 Shares of Merck & Co., Inc. $MRK - MarketBeat
Headlands Technologies LLC Makes New $1.41 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Susquehanna Fundamental Investments LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging - Yahoo Finance
Is Merck Stock Outperforming the Nasdaq? - finance.yahoo.com
Thornburg Investment Management Inc. Acquires 59,303 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Washington Trust Bank - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Benjamin Edwards Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Alyeska Investment Group L.P. - MarketBeat
Merck & Co., Inc. $MRK Stake Decreased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Van ECK Associates Corp Sells 422,266 Shares of Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.41%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):